Analystreport

Revance Therapeutics, Inc. (NASDAQ: RVNC) had its price target raised by analysts at Barclays PLC from $22.00 to $35.00.

Revance Therapeutics, Inc.  (RVNC) 
Last revance therapeutics, inc. earnings: 2/24 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.revance.com